Fcγ receptors as regulators of immune responses
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
In addition to their role in binding antigen, antibodies can regulate immune responses through interacting with Fc receptors (FcRs). In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo. In this Review, we discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcgammaRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FcγR activation induces macrophage phagocytosis.44”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [44]
Citations
Cites
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Self-citationShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · cited 1×
“Evidence that this sugar residue is involved in immune regulatory processes was obtained by studying the mechanism of the anti-inflammatory activity of IVIG therap”
BackgroundSelf-citationDifferential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307 · cited 1×
“This sugar side chain consists of a conserved biantennary heptasaccharide core structure containing mannose and N-acetylglucosamine (GlcNac) with varying additions of terminal and branching residues such as fucose, GlcNac, galactose and sialic aci”
BackgroundWeng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300 · cited 1×
“Several studies of lymphoma patients who had received Rituximab, a B-cell depleting chimeric IgG1 antibody that is specific for CD20, revealed that those patients with activating FcγR alleles that had a higher binding affinity for the Fc fragment of the therapeutic antibody displayed significantly improved clinical re…”
Background
Cited by
Items 501–600 of 1,008
Burke, M. J., & Zalewska‐Szewczyk, B. (2022) · Future Oncology · doi:10.2217/fon-2021-1288 · Cited by 74
Verí, M.-C., Burke, S., Huang, L., Li, H., Gorlatov, S. N., Tuaillon, N., Rainey, G. J., Ciccarone, V. C., Zhāng, T., Shah, K., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27477 · Cited by 74
The B cell helper side of neutrophils
Cerutti, A., Puga, I., & Magri, G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1112596 · Cited by 75
Recent Advances in Kawasaki Disease
Kim, K. Y., & Kim, D. S. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.1.15 · Cited by 74
Chen, M., Xiao, C., Lao, X., Yuan, W., Liu, R., Zeng, Q., Wang, J., Ouyang, F., Chen, D., Chan, K., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0329 · Cited by 77
Becker, K. L., Aimanianda, V., Wang, X., Gresnigt, M. S., Ammerdorffer, A., Jacobs, C. W., Gazendam, R. P., Joosten, L. A. B., Netea, M. G., Latgé, J. P., et al. (2016) · mBio · doi:10.1128/mbio.01823-15 · Cited by 73
Liu, X., Lu, L., Yang, Z., Palaniyandi, S., Zeng, R., Gao, L.-Y., Mosser, D. M., Roopenian, D. C., & Zhu, X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003584 · Cited by 73
“These receptors interact with Ab–Ag complexes to trigger a variety of responses (17), including the immediate internalization of the Ags in the form of immune complexes (ICs) (18, 19).”
BackgroundShock, A., Humphreys, D. P., & Nimmerjahn, F. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.06.036 · Cited by 81
Self-citationMaterial matters: exploring the interplay between natural biomaterials and host immune system
Tripathi, A. S., Zaki, M. E. A., Al‐Hussain, S. A., Dubey, B. K., Singh, P., Rind, L., & Yadav, R. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1269960 · Cited by 78
IgG1 protects against renal disease in a mouse model of cryoglobulinaemia
Strait, R. T., Posgai, M. T., Mahler, A. M., Barasa, N., Jacob, C. O., Köhl, J., Ehlers, M., Stringer, K. F., Shanmukhappa, S. K., Witte, D. P., et al. (2014) · Nature · doi:10.1038/nature13868 · Cited by 73
RAGE binds C1q and enhances C1q-mediated phagocytosis
Ma, W., Rai, V., Hudson, B. I., Song, F., Schmidt, A. M., & Barile, G. R. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.02.001 · Cited by 79
Considerations for the development of therapeutic monoclonal antibodies
Swann, P. G., Tolnay, M., Muthukkumar, S., Shapiro, M. A., Rellahan, B. L., & Clouse, K. A. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.013 · Cited by 78
Human gene copy number variation and infectious disease
Hollox, E. J., & Hoh, B. (2014) · Human Genetics · doi:10.1007/s00439-014-1457-x · Cited by 85
The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden
Boross, P., Jansen, J. H. M., de Haij, S., Beurskens, F. J., van der Poel, C. E., Bevaart, L., Nederend, M., Golay, J., van de Winkel, J. G. J., Parren, P. W. H. I., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.047159 · Cited by 74
Vire, B., David, A., & Wiestner, A. U. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100532 · Cited by 75
Tec Family Kinases in Inflammation and Disease
Horwood, N. J., Urbaniak, A. M., & Danks, L. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2012.670334 · Cited by 79
Hayes, J. M., Frostell, Å., Karlsson, R., Müller, S., Millán‐Martín, S., Pauers, M., Reuss, F., Cosgrave, E. F. J., Annerén, C., Davey, G. P., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m117.066944 · Cited by 83
Setting the target for pemphigus vulgaris therapy
Ellebrecht, C. T., & Payne, A. S. (2017) · JCI Insight · doi:10.1172/jci.insight.92021 · Cited by 80
Bianco, B., André, G. M., Vilarino, F. L., Peluso, C., Mafra, F. A., Christofolini, D. M., & Barbosa, C. P. (2012) · Human Immunology · doi:10.1016/j.humimm.2011.12.009 · Cited by 72
“Indeed, studies in mouse models have highlighted the role of FCGR2B in the development of autoimmune diseases [75–79].”
BackgroundChoi, D.-K., Bae, J., Shin, S.-M., Shin, J.-Y., Kim, Y., & Kim, Y. (2014) · mAbs · doi:10.4161/mabs.36389 · Cited by 73
Bröker, B. M., Holtfreter, S., & Bekeredjian‐Ding, I. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.11.008 · Cited by 80
The carbohydrate switch between pathogenic and immunosuppressive antigen‐specific antibodies
Collin, M., & Ehlers, M. (2013) · Experimental Dermatology · doi:10.1111/exd.12171 · Cited by 73
Liu, S. D., Chalouni, C. M., Young, J. C., Junttila, T. T., Sliwkowski, M. X., & Lowe, J. B. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0125 · Cited by 80
Fcγ Receptors and Ligands and Cardiovascular Disease
Tanigaki, K., Sundgren, N. C., Khera, A., Vongpatanasin, W., Mineo, C., & Shaul, P. W. (2015) · Circulation Research · doi:10.1161/circresaha.116.302795 · Cited by 79
Neutrophil FcγRIIA promotes IgG-mediated glomerular neutrophil capture via Abl/Src kinases
Nishi, H., Furuhashi, K., Culleré, X., Saggu, G., Miller, M. J., Chen, Y., Rosetti, F., Hamilton, S., Yang, L., Pittman, S. P., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94039 · Cited by 76
“Mice deficient in the FcγR γ chain (γ–/–), essential for the expression and function of all murine activating FcγRs, exhibit a marked reduction in leukocyte accumulation and renal injury in acute and rapidly progressive anti-GBM antibody–induced GN, and in a lupus-prone NZB/W background (6, 7).”
Klánová, M., Oestergaard, M. Z., Trněný, M., Hiddemann, W., Marcus, R. E., Sehn, L. H., Vitolo, U., Bazeos, A., Goede, V., Zeuner, H., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3270 · Cited by 76
Ortiz, D. F., Lansing, J. C., Rutitzky, L., Kurtagic, E., Prod’homme, T., Choudhury, A., Washburn, N., Bhatnagar, N., Beneduce, C., Holte, K., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9418 · Cited by 67
Self-citationFoster, M., Hill, P. C., Setiabudiawan, T. P., Koeken, V. A. C. M., Alisjahbana, B., & van Crevel, R. (2021) · Immunological Reviews · doi:10.1111/imr.12965 · Cited by 88
Kurokawa, K., Jung, D.-J., An, J.-H., Fuchs, K., Jeon, Y.-J., Kim, N.-H., Li, X., Tateishi, K., Park, J. A., Xia, G., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.509893 · Cited by 73
New developments in C5a receptor signaling
Ward, P. A., & Sarma, J. V. (2012) · Cell Health and Cytoskeleton · doi:10.2147/chc.s27233 · Cited by 79
Silva, D. G., Daley, S. R., Hogan, J., Lee, S. K., Teh, C. E., Hu, D. Y., Lam, K.-P., Goodnow, C. C., & Vinuesa, C. G. (2011) · Diabetes · doi:10.2337/db10-1344 · Cited by 72
Cutting Edge: FcR-Like 6 Is an MHC Class II Receptor
Schreeder, D. M., Cannon, J. P., Wu, J., Li, R., Shakhmatov, M. A., & Davis, R. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000832 · Cited by 77
Bartsch, Y. C., Rahmöller, J., Mertes, M. M. M., Eiglmeier, S., Lorenz, F. K. M., Stoehr, A. D., Braumann, D., Lorenz, A., Winkler, A., Lilienthal, G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01183 · Cited by 75
“The ability of IgG antibodies (Abs) to modulate immune responses depends on the Ab subclass and the structure of the N-glycan attached to Asn-297 in the Fc region that affect IgG binding to activating and inhibitory Fcγ receptors (FcγRs) on effector cells (1, 2).”
BackgroundInhibitory Fcγ Receptor Is Required for the Maintenance of Tolerance through Distinct Mechanisms
Li, F., Smith, P. T., & Ravetch, J. V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302934 · Cited by 70
Self-citationTight nanoscale clustering of Fcγ receptors using DNA origami promotes phagocytosis
Kern, N., Dong, R., Douglas, S. M., Vale, R. D., & Morrissey, M. A. (2021) · eLife · doi:10.7554/elife.68311 · Cited by 79
Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
Smith, E. L., Giddens, J. P., Iavarone, A. T., Godula, K., Wang, L., & Bertozzi, C. R. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500061s · Cited by 85
Siliņa, K., Rulle, U., Kalniņa, Z., & Linē, A. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1544-9 · Cited by 78
“An explanation of such discrepancies might be the different affinities of various IgG subclasses with the activating and inhibitory Fc gamma receptors (FcγR) [72].”
BackgroundIsotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity
Yu, X., Chan, H. T. C., Fisher, H., Penfold, C. A., Kim, J., Inzhelevskaya, T., Mockridge, C. I., French, R. R., Duriez, P. J., Douglas, L. R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.013 · Cited by 78
“…IgG in serum was not due to peripheral B cell depletion, we generated deglycosylated 341G2 hIgG1, lacking Fc effector functions (Lux et al., 2013; Nimmerjahn and Ravetch, 2008), which effectively suppressed the anti-OVA IgG response but did not result in B cell depletion (Figures 2D and 2E).”
BackgroundMicroglia are continuously activated in the circumventricular organs of mouse brain
Takagi, S., Furube, E., Nakano, Y., Morita, M., & Miyata, S. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.10.008 · Cited by 70
Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation
Golay, J., Valgardsdottir, R., Musaraj, G., Giupponi, D., Spinelli, O., & Introna, M. (2019) · Blood · doi:10.1182/blood-2018-07-864538 · Cited by 76
Antibodies to wounded tissue enhance cutaneous wound healing
Nishio, N., Ito, S., Suzuki, H., & Isobe, K. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03119.x · Cited by 70
An integrated approach for measuring copy number variation at theFCGR3(CD16) locus
Hollox, E. J., Detering, J.-C., & Dehnugara, T. (2009) · Human Mutation · doi:10.1002/humu.20911 · Cited by 70
“C Funders A uthor M anuscripts E urope PM C Funders A uthor M anuscripts Fcγ receptors act as cellular receptors for the Fc region of IgG and IgE, and transmit their signal inside the cell either by tyrosine-based activation (ITAM) or inhibitory motifs (ITIM) (Nimmerjahn and Ravetch, 2008).”
BackgroundFcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo
Baerenwaldt, A., Lux, A., Danzer, H., Spriewald, B. M., Ullrich, E., Heidkamp, G., Dudziak, D., & Nimmerjahn, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111810108 · Cited by 69
Self-citationPharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy
Murdaca, G., Spanò, F. M., Contatore, M., Guastalla, A., Magnani, O., & Puppo, F. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.970165 · Cited by 69
Moraru, M., Black, L. E., Muntasell, A., Portero, F., López‐Botet, M., Reyburn, H. T., Pandey, J. P., & Vilches, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500872 · Cited by 69
The Impact of FcγRI Binding on Immuno-PET
Vivier, D., Sharma, S. K., Adumeau, P., Rodríguez, C. M. A., Fung, K., & Zeglis, B. M. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.223636 · Cited by 72
Wu, N., Zhong, M., Roncagalli, R., Pérez‐Quintero, L., Guo, H., Zhang, Z., Lenoir, C., Dong, Z., Latour, S., & Veillette, A. (2016) · Nature Immunology · doi:10.1038/ni.3369 · Cited by 68
Crowley, A. R., & Ackerman, M. E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00697 · Cited by 68
Melki, I., Allaeys, I., Tessandier, N., Mailhot, B., Cloutier, N., Campbell, R. A., Rowley, J. W., Salem, D., Zufferey, A., Laroche, A., et al. (2020) · Blood · doi:10.1182/blood.2020004974 · Cited by 70
van Egmond, M., Vidarsson, G., & Bakema, J. E. (2015) · Immunological Reviews · doi:10.1111/imr.12333 · Cited by 74
Braza, M. S., Klein, B., Fiol, G., & Rossi, J. (2010) · Haematologica · doi:10.3324/haematol.2010.029520 · Cited by 75
Ramakrishna, C., Newo, A. N. S., Shen, Y.-W., & Cantin, E. M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002071 · Cited by 68
“IVIG is a FDA approved treatment for immune thrombocytopenia (ITP) and Kawasaki's vasculitis, and dramatic response rates that exceed 80% have been observed for ITP. The use of IVIG for treating a variety of autoimmune and systemic inflammatory diseases has steadily increased to include not only antibody mediated dise…”
BackgroundAntigen-Induced Oligomerization of the B Cell Receptor Is an Early Target of FcγRIIB Inhibition
Liu, W., Sohn, H. W., Tolar, P., Meckel, T., & Pierce, S. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902334 · Cited by 68
“The FcgRIIB blocks BCR signaling cascades when colligated to the BCR through the binding of Ag-containing immune complexes (ICs) (4).”
BackgroundThe Humoral Response to HIV‐1: New Insights, Renewed Focus
Alter, G., & Moody, M. A. (2010) · The Journal of Infectious Diseases · doi:10.1086/655654 · Cited by 93
“All of these activities are triggered after the interaction of the CH2 domain of the antibody with circulating complement or Fc receptors found on immune cells (Figure 2) [55, 56].”
Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway
Benedetti, E., Pučić‐Baković, M., Keser, T., Wahl, A., Hassinen, A., Yang, J., Liu, L., Trbojević‐Akmačić, I., Razdorov, G., Štambuk, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01525-0 · Cited by 84
“…and secreted by B lymphocytes and has two functional domains: an antigen-binding fragment (Fab), which is responsible for recognizing antigens on foreign pathogens and infected cells and a crystallizable fragment (Fc), which triggers the immune response by interacting with various Fc receptors 3 .”
InfluentialGaifem, J., Rodrigues, C. S., Petralia, F., Alves, I., Leite-Gomes, E., Cavadas, B., Dias, A. M., Moreira-Barbosa, C., Revés, J., Laird, R. M., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01916-8 · Cited by 77
“…from serum is composed of multiple glycoforms owing to the addition of a diverse repertoire of glycan structures on the IgG crystallizable fragment (Fc) region, a conserved domain responsible for modulating IgG effector functions through interactions with Fcγ receptors (FcγRs) on immune cells 17 .”
Ward, E. S., Mittereder, N., Kuta, E. G., Sims, G. P., Bowen, M. A., Dall’Acqua, W. F., Tedder, T. F., Kiener, P. A., Coyle, A. J., Wu, H., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08857.x · Cited by 67
“The relevant activating Fcc receptor on human NK cells is FccRIIIA, which normally binds human IgG1 Fc with low affinity (Nimmerjahn & Ravetch, 2008).”
BackgroundTsai, T.-T., Chuang, Y.-J., Lin, Y.-S., Chang, C., Wan, S.-W., Lin, S. H., Chen, C.-L., & Lin, C. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003320 · Cited by 79
Syed, S. N., Konrad, S., Wiege, K., Nieswandt, B., Nimmerjahn, F., Schmidt, R. E., & Gessner, J. E. (2009) · European Journal of Immunology · doi:10.1002/eji.200939884 · Cited by 67
Self-citationMajewska, N. I., Tejada, M. L., Betenbaugh, M. J., & Agarwal, N. (2020) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-102419-010001 · Cited by 81
“Intracellular signaling via FcγRIIb, the only known inhibitory receptor, is modulated via phosphorylation of the immunoreceptor tyrosine-based inhibitory motif, leading to the recruitment of phosphatases that counteract the activating signals (11).”
BackgroundRole of Calcium Signaling in B Cell Activation and Biology
Baba, Y., & Kurosaki, T. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_477 · Cited by 84
Qu, L., Li, Y., Pan, X., Zhang, P., LaMotte, R. H., & Ma, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6355-11.2012 · Cited by 66
“Moreover, Fc Rs, expressed on immune cells, appear to play an important role in this process (Nimmerjahn and Ravetch, 2006, 2008).”
BackgroundCrispin, M., Bowden, T. A., Coles, C. H., Harlos, K., Aricescu, A. R., Harvey, D. J., Stuart, D. I., & Jones, E. Y. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.033 · Cited by 72
Epidermolysis bullosa acquisita
Kim, J. H., & Kim, S. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12096 · Cited by 67
Illouz, T., Biragyn, A., Iulita, M. F., Aguilar, L. F., Dierssen, M., Toma, I. D., Antonarakis, S. E., Yu, E. Y., Hérault, Y., Potier, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621440 · Cited by 76
“Cross-linking of Fc receptors and high af fi nity binding to Igs occur when these antibodies recognize pathogens or infected cells, stimulating phagocytosis of opsonized microbes by monocytes, macrophages, neutrophils, and DC or their destruction by cytotoxic effector cells (108).”
Don't eat me/eat me signals as a novel strategy in cancer immunotherapy
Khalaji, A., Yancheshmeh, F. B., Farham, F., Khorram, A., Sheshbolouki, S., Zokaei, M., Vatankhah, F., & Soleymani-Goloujeh, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20507 · Cited by 72
“Fc receptors, which belong to a family of receptors located on the cell surface, bind to the Fc domain of immunoglobulins and initiate downstream signaling in immune cells [107,108].”
Neutrophils in cancer: from biology to therapy
Koenderman, L., & Vrisekoop, N. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01244-9 · Cited by 75
The Wnt signaling pathway is involved in the regulation of phagocytosis of virus in Drosophila
Zhu, F., & Zhang, X. (2013) · Scientific Reports · doi:10.1038/srep02069 · Cited by 70
Moldt, B., Schultz, N., Dunlop, D. C., Alpert, M. D., Harvey, J. D., Evans, D. T., Poignard, P., Hessell, A. J., & Burton, D. R. (2011) · Journal of Virology · doi:10.1128/jvi.05541-11 · Cited by 65
Siglec receptors impact mammalian lifespan by modulating oxidative stress
Schwarz, F., Pearce, O. M., Wang, X., Samraj, A. N., Läubli, H., Garcia, J. O., Lin, H., Fu, X., Garcia-Bingman, A., Secrest, P., et al. (2015) · eLife · doi:10.7554/elife.06184 · Cited by 65
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.010 · Cited by 69
Role of F c‐mediated antibody function in protective immunity against HIV ‐1
Lewis, G. K. (2013) · Immunology · doi:10.1111/imm.12232 · Cited by 66
Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy
Phung, S. K., Miller, J. S., & Felices, M. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-021-00550-6 · Cited by 64
“Conversely, in instances where ADCC is not desirable, the Fc binding has also been silenced through genetic manipulation.”
BackgroundInfluentialThe neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases
Sesărman, A., Vidarsson, G., & Sitaru, C. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0318-6 · Cited by 70
van der Poel, C. E., Karssemeijer, R. A., Boross, P., van der Linden, J. A., Blokland‐Fromme, M., van de Winkel, J. G. J., & Leusen, J. H. W. (2010) · Blood · doi:10.1182/blood-2010-04-280214 · Cited by 64
Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity
Bournazos, S., Chow, S.-K., Abboud, N., Casadevall, A., & Ravetch, J. V. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72676 · Cited by 66
Self-citationNeutrophils in lupus nephritis
Nishi, H., & Mayadas, T. N. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000577 · Cited by 68
Targeting the SYK–BTK axis for the treatment of immunological and hematological disorders
Tan, S., Liao, C., Lucas, M. C., Stevenson, C. S., & DeMartino, J. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.02.001 · Cited by 67
“…cells (monocytes/macrophages, basophils, mast cells, neutrophils and DCs) modulate immune-complex induced activation resulting in diverse cellular processes such as phagocytosis, antigen presentation, Ca2+ mobilization and pro-inflammatory cytokine/chemokine production (Nimmerjahn & Ravetch, 2008).”
BackgroundMaternal farm exposure/ingestion of unpasteurized cowʼs milk and allergic disease
von Mutius, E. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835955d3 · Cited by 63
MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response
Pellerin, K., Rubino, S. J., Burns, J. C., Smith, B. A., McCarl, C.-A., Zhu, J., Jandreski, L., Cullen, P., Carlile, T. M., Li, A., et al. (2021) · Brain · doi:10.1093/brain/awab231 · Cited by 62
Ankylosing Spondylitis: From Cells to Genes
Zambrano‐Zaragoza, J. F., Agraz‐Cibrián, J. M., González‐Reyes, C., Durán‐Avelar, M. D. J., & Vibanco‐Pérez, N. (2013) · International Journal of Inflammation · doi:10.1155/2013/501653 · Cited by 75
Suppression of Fcγ-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection
Yamada, D. H., Elsaesser, H. J., Lux, A., Timmerman, J. M., Morrison, S. L., de la Torre, J. C., Nimmerjahn, F., & Brooks, D. G. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.005 · Cited by 65
“…(neutralizing; nAbs), opsonizing free virions, and targeting viral proteins on the surface of infected cells to facilitate cell-killing by either NK cells (Ab-dependent cellular cytotoxicity; ADCC) or phagocytic cells (Ab-dependent cellular phagocytosis; ADCP) (Nimmerjahn and Ravetch, 2008).”
InfluentialSelf-citationFc receptors: Cell activators of antibody functions
Rosales, C., & Uribe‐Querol, E. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.44a004 · Cited by 76
“FcγRIIB expression is inducible in phagocytic leukocytes, for the negative regulation of cell functions, such as phagocytosis [8,26].”
BackgroundInfluentialMechanisms of action of intravenous immunoglobulins
Baerenwaldt, A., Biburger, M., & Nimmerjahn, F. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.9 · Cited by 68
Self-citationFcγ Receptor IIb Strongly Regulates Fcγ Receptor-Facilitated T Cell Activation by Dendritic Cells
van Montfoort, N., Hoen, P. A. C. ’., Mangsbo, S. M., Camps, M. G. M., Boross, P., Melief, C. J. M., OSSENDORP, F. A., & Verbeek, J. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103703 · Cited by 67
León, B., Ballesteros‐Tato, A., Randall, T. D., & Lund, F. E. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131692 · Cited by 64
“…isotype-switched Abs, which are produced within 5–6 d of infection (Lee et al., 2005; Mozdzanowska et al., 2005), control Ag availability by preventing continued infection and by binding Ag and targeting it to Fc receptor (FcR)–expressing phagocytic cells (Nimmerjahn and Ravetch, 2008).”
BackgroundEngelmann, R., Brandt, J., Eggert, M., Karberg, K., Krause, A., Neeck, G., & Mueller‐Hilke, B. (2008) · Rheumatology · doi:10.1093/rheumatology/ken336 · Cited by 63
“Thus, the predominance of IgG4 may indirectly obstruct the elimination of auto-reactive cells of the B lineage and support the accumulation of autoantibodies of the IgG1 subclass [6, 15 ].”
BackgroundImmunoregulatory functions of immune complexes in vaccine and therapy
Wen, Y., Mu, L., & Shi, Y. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606593 · Cited by 69
“ICs in vaccine development and clinical interventions are becoming increasingly sophisticated, largely attributable to the newly gained understanding of Fcc receptors (FccR; Nimmerjahn & Ravetch, 2008; Ravetch, 2010).”
BackgroundImproving Antibody-Based Cancer Therapeutics Through Glycan Engineering
Yu, X., Marshall, M. J. E., Cragg, M. S., & Crispin, M. (2017) · BioDrugs · doi:10.1007/s40259-017-0223-8 · Cited by 71
Tassi, M., Vos, J. D., Chatterjee, S., Sobott, F., Bones, J., & Eeltink, S. (2017) · Journal of Separation Science · doi:10.1002/jssc.201700988 · Cited by 73
Krishnamoorthy, S., Liu, T., Drager, D., Patarroyo-White, S. L., Chhabra, E. S., Peters, R., Josephson, N. C., Lillicrap, D., Blumberg, R. S., Pierce, G. F., et al. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.12.008 · Cited by 68
Hawley, K. L., Cruz, A. R., Benjamin, S. J., Vake, C. J. L., Cervantes, J., LeDoyt, M., Ramírez, L. G., Mandich, D., Fiel-Gan, M. D., Caimano, M. J., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01227 · Cited by 64
Tracing the Origins of IgE, Mast Cells, and Allergies by Studies of Wild Animals
Hellman, L. T., Akula, S., Thorpe, M., & Fu, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01749 · Cited by 63
Neuronal FcγRI mediates acute and chronic joint pain
Wang, L., Jiang, X., Zheng, Q., Jeon, S.-M., Chen, T., Liu, Y., Kulaga, H., Reed, R., Dong, X., Caterina, M. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128010 · Cited by 61
“However, Fc γ RI (also called CD64) is the sole high-affinity receptor that can bind both monomeric and polymeric IgG (16).”
BackgroundInfluentialThe Role of IgG4 in Autoimmunity and Rheumatic Diseases
Maślińska, M., Dmowska-Chalaba, J., & Jakubaszek, M. P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.787422 · Cited by 70
Afucosylated IgG responses in humans – structural clues to the regulation of humoral immunity
Oosterhoff, J. J., Larsen, M. D., van der Schoot, C. E., & Vidarsson, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.08.001 · Cited by 71
“Humans have several activating FcγRs (FcγRI, FcγRIIa, FcγRIIc, FcγRIIIa, and FcγRIIIb) and at least one inhibitory receptor (FcγRIIb) [35].”
Cox, N., Pilling, D., & Gomer, R. H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500956112 · Cited by 62
Wieland, A., Shashidharamurthy, R., Kamphorst, A. O., Han, J., Aubert, R. D., Choudhury, B., Stowell, S. R., Lee, J., Punkosdy, G. A., Shlomchik, M. J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.009 · Cited by 65
“It is important to point out that we only observed impaired FcgR-mediated processes in our in vivo but not in vitro experiments as ICs probably occupy FcgRs in vivo and thus restrict antibody effector functions such as ADCC.”
InfluentialAnderson, K. E., Chessa, T. A. M., Davidson, K., Henderson, R. B., Walker, S., Tolmachova, T., Grys, K., Rausch, O., Seabra, M. C., Tybulewicz, V. L. J., et al. (2010) · Blood · doi:10.1182/blood-2010-03-275602 · Cited by 66
NK Cell Function and Antibodies Mediating ADCC in HIV-1-Infected Viremic and Controller Patients
Johansson, S. E., Rollman, E., Chung, A. W., Hejdeman, B., Stratov, I., Hinkula, J., Wahrén, B., Kärre, K., Kent, S. J., & Berg, L. (2011) · Viral Immunology · doi:10.1089/vim.2011.0025 · Cited by 62
Metadata
- Authors
- Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Rockefeller University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 34-47
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2075901113
- Cited by
- 2,947
- References
- 139
- Citations by year
- 2026: 186 · 2025: 176 · 2024: 158 · 2023: 174 · 2022: 169 · 2021: 196 · 2020: 158 · 2019: 188 · 2018: 151 · 2017: 161 · 2016: 158 · 2015: 170 · 2014: 165 · 2013: 162 · 2012: 181
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- Fc gamma receptor, IgG, antibody subclasses, immune regulation, therapeutic antibodies, autoimmune disease, infectious diseases, cancer immunotherapy, antibody effector functions
- MeSH terms
- Animals, Humans, Immunoglobulin G, Immunity, Receptors, Fc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.